About Hematopoietic SH2 domain-containing protein
Hematopoietic SH2 domain-containing protein (HSH2D) is a protein
from Homo sapiens identified by UniProt accession
Q96JZ2, 352 residues long.
MolForge cross-references it against 0 known binders and
46 disease associations.
Target properties
| Protein name | Hematopoietic SH2 domain-containing protein |
| UniProt accession | Q96JZ2 |
| Gene | HSH2D |
| Organism | Homo sapiens |
| Length | 352 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (46)
Diseases linked to this target (Open Targets).
- mean corpuscular volume · score 0.34
- mean corpuscular hemoglobin concentration · score 0.30
- mean corpuscular hemoglobin · score 0.24
- mean platelet volume · score 0.14
- myeloperoxidase measurement · score 0.13
- Red cell distribution width · score 0.12
- generalized anxiety disorder · score 0.11
- acute lymphoblastic leukemia · score 0.07
- age at onset · score 0.06
- Myopia · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96JZ2-F1 | alphafold | PREDICTED | 62.23 | — |
Amino-acid sequence (352 residues)
MTEAGKLPLP LPPRLDWFVH TQMGQLAQDG VPEWFHGAIS REDAENLLES QPLGSFLIRV SHSHVGYTLS YKAQSSCCHF MVKLLDDGTF MIPGEKVAHT SLDALVTFHQ QKPIEPRREL LTQPCRQKDP ANVDYEDLFL YSNAVAEEAA CPVSAPEEAS PKPVLCHQSK ERKPSAEMNR ITTKEATSSC PPKSPLGETR QKLWRSLKML PERGQRVRQQ LKSHLATVNL SSLLDVRRST VISGPGTGKG SQDHSGDPTS GDRGYTDPCV ATSLKSPSQP QAPKDRKVPT RKAERSVSCI EVTPGDRSWH QMVVRALSSQ ESKPEHQGLA EPENDQLPEE YQQPPPFAPG YC
Explore Hematopoietic SH2 domain-containing protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets